中天金融(000540.SZ):終止回購部分社會公眾股份
格隆匯12月13日丨中天金融(000540.SZ)公佈,2019年12月13日,公司召開第八屆董事會第5次會議、第八屆監事會第4次會議,審議通過《關於終止以集中競價交易方式回購部分社會公眾股份暨實施結果的議案》,獨立董事對此次終止股份回購事項發表了同意的意見。
自2019年1月2日至2019年8月6日期間,公司實施此次股份回購方案已累計通過回購專用證券賬户以集中競價交易方式回購股份數量2077.4918股,佔公司總股本的0.30%;此次回購股份最高成交價為5.21元/股,回購股份最低成交價為3.32元/股,共支付金額8356.57萬元(含交易費用)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.